Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.2292 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about SciSparc Ltd. - Ordinary Shares < Previous 1 2 3 4 5 6 7 8 9 Next > Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome September 30, 2024 SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon. Via Benzinga Exposures Product Safety Clearmind Medicine Files International Patent For Ibogaine Combination Therapy September 17, 2024 Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket September 17, 2024 Via Benzinga Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket August 29, 2024 Via Benzinga Why Is SciSparc (SPRC) Stock Up 94% Today? August 15, 2024 SciSparc stock is up on Thursday with heavy trading of SPRC shares after it provided an update on its merger with AutoMax. Via InvestorPlace Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket August 26, 2024 Via Benzinga Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients August 20, 2024 SciSparc Ltd. (NASDAQ: SPRC) announced on Tuesday that the first five patients have been enrolled and dosed into its ongoing clinical trial in children suffering from autism spectrum disorder (ASD) at... Via Benzinga Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy August 19, 2024 SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties. Via Benzinga Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket August 19, 2024 Via Benzinga Nasdaq Jumps Over 2%; Walmart Earnings Top Views August 15, 2024 Via Benzinga Dow Surges Over 500 Points; US Retail Sales Rise In July August 15, 2024 Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 15, 2024 Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today! Via InvestorPlace Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket August 15, 2024 Via Benzinga Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga Mizuho Just Issued a Warning on Palantir (PLTR) Stock July 16, 2024 Palantir Technologies stock is down on Tuesday after shares of PLTR were hit with a downgrade from Mizuho analysts this morning. Via InvestorPlace Why Is SciSparc (SPRC) Stock Up 25% Today? July 16, 2024 SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment. Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 16, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! Via InvestorPlace Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket July 11, 2024 Via Benzinga Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Via Benzinga Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket April 16, 2024 Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into... Via Benzinga Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification April 11, 2024 SciSparc to acquire AutoMax Motors, forming a new entity with SciSparc owning over 50%. SciSparc's core operations to continue. Via Benzinga Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket April 11, 2024 Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... Via Benzinga Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors March 12, 2024 Via Benzinga Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments March 08, 2024 The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds February 27, 2024 Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents February 21, 2024 SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health. Via Benzinga Topics Intellectual Property Exposures Intellectual Property What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? February 20, 2024 SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 20, 2024 Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.